Format

Send to:

Choose Destination
See comment in PubMed Commons below
Life Sci. 2013 Mar 19;92(8-9):520-4. doi: 10.1016/j.lfs.2012.07.028. Epub 2012 Aug 1.

Modulation of the cannabinoid receptors by hemopressin peptides.

Author information

  • 1Center for Advanced Drug Research (CADRE), SRI International, United States.

Abstract

Changes in the endocannabinoid system are implicated in numerous diseases, making it an attractive target for pharmaceutical development. The endocannabinoid receptors have traditionally been thought to act through the effects of lipophilic messengers called cannabinoids. The exciting finding of endocannabinoid system modulation by the nonapeptide hemopressin and its N-terminal extensions has highlighted the complexity of cannabinoid biology and pharmacology and sparked interest for therapeutic purposes. However, many questions surrounding the generation and regulation of the hemopressin peptides, the self-assembly of hemopressin and the potential for drug development based on hemopressin remain and are discussed in this review.

Copyright © 2012 Elsevier Inc. All rights reserved.

PMID:
22884803
[PubMed - indexed for MEDLINE]
PMCID:
PMC3594051
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk